Company / R&D per Share
STAAR Surgical Company R&D per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$0.81
FY2025
5-year range
$0.54 / $0.93
FY2021-FY2025
Trend
-12.4%
vs FY2024
Sector context
#76 of 108
Health Care
What the data says
At $0.81, STAAR Surgical Company's r&d per share ranks #76 of 108 in the Health Care sector. R&D per Share has fluctuated over the past 10 years, ranging from $0.49 in FY2020 to $518.16 in FY2016.
Based on SEC 10-K filings.
0.81 in FY2025 with a 5-year CAGR of +10.6%.
Declined from $0.84 to $0.81 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +2.5%
- 5-Year CAGR
- +10.6%
- 10-Year CAGR
- -
Sector benchmark
#76 of 108 in Health CareTop 70% of 108This company $0.81 Sector average $2.07
▼
-60.8% below sector average
Key checks
Key Insights
- In FY2025, r&d per share decreased 12.4% year-over-year.
- Ranks #76 out of 108 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2016.
- Lowest r&d per share in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Negative profit margin: -6.4%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.81 | -12.4% |
| FY2024 | $0.93 | +10.5% |
| FY2023 | $0.84 | +11.3% |
| FY2022 | $0.75 | +38.6% |
| FY2021 | $0.54 | +10.7% |
| FY2020 | $0.49 | -14.1% |
| FY2019 | $0.57 | +14.6% |
| FY2018 | $0.50 | -99.9% |
| FY2017 | $362.39 | -30.1% |
| FY2016 | $518.16 | +34.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026